Approvals/TGA/PRALUENT alirocumab 75mg/mL, solution for injection, pre-filled syringe

Approved

STANDARD

PRALUENT alirocumab 75mg/mL, solution for injection, pre-filled syringe

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: baffdbfeefd9cd5d
Product Name: PRALUENT alirocumab 75mg/mL, solution for injection, pre-filled syringe
Artg Id: 238304
Artg Name: PRALUENT alirocumab (rch) 75mg/mL solution for injection pre-filled syringe
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2016-05-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/bb8f5d77deb5f86b1d6fe78f9dfedb79.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/83c34478681b549984b83717bde291e5.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

baffdbfeefd9cd5d

Type

Standard